Journal of hepato-biliary-pancreatic sciences (J Hepatobiliary Pancreat Sci)

Journal PubWeight™ 513.33‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. 2015 2.63
2 TG13 antimicrobial therapy for acute cholangitis and cholecystitis. 2013 2.23
3 Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma. 2014 2.22
4 Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. 2014 2.07
5 Management strategy for biliary stricture following laparoscopic cholecystectomy. 2014 2.03
6 Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. 2012 1.98
7 An extended dysfunctional area in the congestive area of the remnant liver after hemi-hepatectomy with middle hepatic vein resection for liver cancers evaluated on the gadoxetic acid disodium-enhanced magnetic resonance imaging. 2013 1.97
8 TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). 2013 1.84
9 TG13 flowchart for the management of acute cholangitis and cholecystitis. 2013 1.82
10 Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. 2012 1.72
11 TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). 2013 1.66
12 Parenchyma-sparing resections for pancreatic neoplasms. 2009 1.63
13 TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. 2013 1.53
14 Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. 2015 1.52
15 Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. 2014 1.49
16 New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. 2012 1.49
17 Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. 2009 1.44
18 Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. 2009 1.44
19 Ischemic preconditioning prior to intermittent Pringle maneuver in liver resections. 2012 1.44
20 Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. 2013 1.42
21 JPN guidelines 2010. Foreword. 2010 1.41
22 TG13 surgical management of acute cholecystitis. 2013 1.39
23 Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. 2009 1.38
24 Multicenter retrospective study of endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction in Japan. 2013 1.34
25 European experience of laparoscopic major hepatectomy. 2013 1.33
26 Significance of mucin expression in pancreatobiliary neoplasms. 2009 1.31
27 A new classification for hepatocellular carcinoma with portal vein tumor thrombus. 2011 1.29
28 Virtual liver resection: computer-assisted operation planning using a three-dimensional liver representation. 2013 1.23
29 New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. 2012 1.23
30 Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. 2013 1.23
31 International experience for laparoscopic major liver resection. 2014 1.23
32 Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. 2015 1.22
33 Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. 2012 1.20
34 Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. 2015 1.19
35 Roles of liver fluke infection as risk factor for cholangiocarcinoma. 2014 1.18
36 Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2011 1.18
37 The current potential of high-intensity focused ultrasound for pancreatic carcinoma. 2011 1.17
38 A novel difficulty scoring system for laparoscopic liver resection. 2014 1.17
39 The learning curve in laparoscopic major liver resection. 2013 1.16
40 Augmented reality and image overlay navigation with OsiriX in laparoscopic and robotic surgery: not only a matter of fashion. 2011 1.16
41 Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach. 2009 1.16
42 A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. 2012 1.16
43 Intraoperative fluorescent imaging using indocyanine green for liver mapping and cholangiography. 2009 1.15
44 Stent selection and tips on placement technique of EUS-guided biliary drainage: transduodenal and transgastric stenting. 2011 1.15
45 Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. 2015 1.15
46 Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. 2012 1.14
47 Endoscopic ultrasonography-guided biliary drainage. 2009 1.13
48 Intraoperative exploration of biliary anatomy using fluorescence imaging of indocyanine green in experimental and clinical cholecystectomies. 2009 1.13
49 Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective. 2009 1.13
50 Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. 2012 1.12
Next 50